ICD-10-CM Billable Code

B02.22

Postherpetic trigeminal neuralgia

Clinical Classification Guidelines

Medical Intelligence & Overview

Postherpetic trigeminal neuralgia is a nerve disorder characterized by persistent, severe facial pain following an outbreak of herpes zoster, commonly known as shingles. It results from nerve damage caused by the varicella-zoster virus, which reactivates in the facial nerve area. This condition primarily affects the trigeminal nerve, a major nerve responsible for sensation in the face. While shingles typically causes a painful rash, some individuals develop ongoing nerve pain after the rash has healed, leading to postherpetic neuralgia, with trigeminal neuralgia being a specific manifestation affecting the face.

Causes & Symptoms

Clinical Causes: Reactivation of the varicella-zoster virus in the trigeminal nerve Nerve damage caused by shingles affecting the facial region Age-related decline in immune system function Increased susceptibility in individuals with weakened immune defenses

Key Symptoms: Sharp, stabbing facial pain that can be intense Persistent aching or burning sensation in the face Pain often localized to one side of the face, typically along the distribution of the trigeminal nerve Sensitivity to touch or mild stimuli like wind or clothing Episodes of pain that may last from seconds to minutes, with some experiencing continuous discomfort In some cases, facial muscles may be affected, leading to weakness or twitching

Diagnostic & Treatment

Diagnosis Path: Diagnosis of postherpetic trigeminal neuralgia involves a detailed review of medical history, including previous shingles outbreaks. A physical examination focuses on assessing facial sensation and nerve function. Healthcare providers may recommend imaging studies, such as MRI scans, to rule out other conditions affecting the nerves or brain structures. Diagnosis largely depends on characteristic symptoms and history of herpes zoster in the facial area.

Treatment Protocols: Medications like anticonvulsants (e.g., carbamazepine), tricyclic antidepressants, or pain relievers Topical agents such as capsaicin cream or lidocaine patches Nerve blocks or injections to temporarily alleviate pain Physical therapy to improve nerve mobility and reduce discomfort In some cases, surgical procedures may be considered if medication management is ineffective

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is B02.22 a billable ICD-10 code?
Yes, B02.22 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report B02.22?
Clinical documentation must specify the nature of Postherpetic trigeminal neuralgia and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

trigeminal postherpetic neuralgia